Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
January 10, 2016
Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned Biosciences Business Spin-Off
...
Read More
December 22, 2015
Emergent BioSolutions Announces Composition of Board of Directors of New Spin-Off Company Aptevo Therapeutics
...
Read More
December 21, 2015
Emergent BioSolutions to Participate in First Quarter 2016 Investor Conferences
...
Read More
November 24, 2015
FDA Approves Emergent BioSolutions’ BioThrax for Post-Exposure Prophylaxis
...
Read More
November 5, 2015
Emergent BioSolutions Reports Third Quarter and Nine Months 2015 Financial Results
...
Read More
October 22, 2015
Emergent BioSolutions to Release Third Quarter 2015 Financial Results and Conduct a Conference Call on November 5, 2015
...
Read More
August 13, 2015
Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program
...
Read More
August 6, 2015
Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a Separate Publicly-Traded Company
...
Read More
August 6, 2015
Emergent BioSolutions Reports Second Quarter and Six Months 2015 Financial Results and Reaffirms 2015 Guidance
...
Read More
August 3, 2015
Emergent BioSolutions Expands Biodefense Business Through Launch of a Military-Grade Auto-Injector Device for Chemical Threats
...
Read More
July 23, 2015
Emergent BioSolutions to Release Second Quarter 2015 Financial Results and Conduct a Conference Call on August 6, 2015
...
Read More
July 20, 2015
Emergent BioSolutions Awarded $19.7 Million BARDA Contract to Develop and Manufacture Ebola Monoclonal Antibodies
...
Read More
1
2
…
29
30
31
…
58
59
